venBio Select Advisor as of Dec. 31, 2016
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 39 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 10.1 | $49M | 1.7M | 28.84 | |
| Immunomedics | 7.3 | $35M | 9.6M | 3.67 | |
| BioMarin Pharmaceutical (BMRN) | 6.9 | $33M | 400k | 82.84 | |
| Lion Biotechnologies | 6.5 | $31M | 4.5M | 6.95 | |
| Tesaro | 6.5 | $31M | 232k | 134.48 | |
| Neuroderm Ltd F | 4.9 | $23M | 1.1M | 22.20 | |
| Dermira | 4.8 | $23M | 766k | 30.33 | |
| Aerie Pharmaceuticals | 4.8 | $23M | 610k | 37.85 | |
| Neurocrine Biosciences (NBIX) | 4.3 | $21M | 541k | 38.70 | |
| Alexion Pharmaceuticals | 4.3 | $21M | 170k | 122.35 | |
| Amicus Therapeutics (FOLD) | 4.1 | $20M | 4.0M | 4.97 | |
| Agenus | 4.1 | $20M | 4.8M | 4.12 | |
| Bristol Myers Squibb (BMY) | 3.5 | $17M | 285k | 58.44 | |
| Seattle Genetics | 3.2 | $16M | 296k | 52.77 | |
| Global Blood Therapeutics In | 3.0 | $14M | 996k | 14.45 | |
| Ascendis Pharma A S (ASND) | 2.3 | $11M | 545k | 20.24 | |
| Teligent | 2.3 | $11M | 1.7M | 6.61 | |
| BioCryst Pharmaceuticals (BCRX) | 2.1 | $10M | 1.6M | 6.33 | |
| Akebia Therapeutics (AKBA) | 1.8 | $8.7M | 832k | 10.41 | |
| Mirati Therapeutics | 1.5 | $7.2M | 1.5M | 4.75 | |
| Sorrento Therapeutics (SRNE) | 1.5 | $7.1M | 1.5M | 4.90 | |
| Veracyte (VCYT) | 1.5 | $7.0M | 907k | 7.74 | |
| Vanda Pharmaceuticals (VNDA) | 1.3 | $6.1M | 382k | 15.95 | |
| Sarepta Therapeutics (SRPT) | 1.0 | $4.8M | 1.2M | 4.10 | |
| Alimera Sciences | 0.9 | $4.4M | 4.0M | 1.08 | |
| Cascadian Therapeutics | 0.8 | $4.0M | 921k | 4.31 | |
| Xencor (XNCR) | 0.7 | $3.3M | 125k | 26.32 | |
| Assembly Biosciences | 0.7 | $3.3M | 270k | 12.15 | |
| Fortress Biotech | 0.7 | $3.2M | 1.2M | 2.70 | |
| Corvus Pharmaceuticals (CRVS) | 0.6 | $3.1M | 217k | 14.30 | |
| Oncobiologics | 0.4 | $2.1M | 684k | 3.01 | |
| Cellectis S A (CLLS) | 0.3 | $1.6M | 97k | 16.95 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.3 | $1.5M | 6.0M | 0.25 | |
| Array BioPharma | 0.3 | $1.4M | 160k | 8.79 | |
| Trillium Therapeutics, Inc. Cmn | 0.3 | $1.3M | 227k | 5.65 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.2 | $1.2M | 1.1M | 1.05 | |
| BioDelivery Sciences International | 0.2 | $1.1M | 644k | 1.75 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $184k | 233k | 0.79 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $44k | 233k | 0.19 |
